Why the study?
Do MR plaque imaging findings (T1-SIR and T2-SIR) and clinical factors predict the risk of new ischemic brain lesions on DWI following CEA or CAS in patients with carotid stenosis?
Do MR plaque imaging findings (T1-SIR and T2-SIR) and clinical factors predict the risk of new ischemic brain lesions on DWI following CEA or CAS in patients with carotid stenosis?
A prediction model incorporating MR plaque imaging (T1-SIR and T2-SIR) and treatment type (CAS vs CEA) can estimate the individualized risk of new ischemic brain lesions after carotid interventions.
MR plaque imaging may refine individualized periprocedural DWI risk estimates after carotid intervention; leaves open prospective validation before clinical use.
BACKGROUND AND PURPOSE: Findings on MR imaging of carotid plaques correlate with histologic findings and may be useful in identifying vulnerable plaques. The objective of this study was to show how MR imaging findings and clinical factors could be used to construct a preliminary model and a nomogram for predicting the risk of new ischemic lesions on DWI following CEA or CAS. MATERIALS AND METHODS: One hundred four patients with carotid stenosis undergoing treatment (63 CEA, 41 CAS) were prospectively enrolled (mean age, 71.7 ± 7.0 years; 11 women). T1-SIR and T2-SIR of carotid plaque were measured on MR imaging. Associations among carotid MR imaging findings, treatment procedures, degree of stenosis, cardiovascular risk factors, and occurrence of new ischemic lesions on DWI 1 day after treatment were studied by multivariate logistic regression. RESULTS: One stroke occurred after CAS (2.4%), and none after CEA. New DWI lesions after treatment were observed in 25 patients (24%). Our preliminary prediction model demonstrated that T1-SIR (OR [per 0.5 increase], 3.99; 95% CI, 2.18-7.31; P < .0001) and CAS (OR, 2.06; 95% CI, 1.01-4.24; P = .048 compared with CEA) were positively associated with new DWI lesions on posttreatment DWI scans. T2-SIR (OR [per 0.5 increase], 0.74; 95% CI, 0.55-0.98; P = .037) was negatively associated. The C-index of this model was 0.79 (95% CI, 0.69-0.89), which indicated some utility in predicting the response. CONCLUSIONS: Our preliminary prediction model and nomogram may provide an individualized risk estimate of new ischemic lesions after CEA or CAS and useful information for decision-making regarding treatment strategy.
No takes yet. Share an insight, caveat, or question.
Akutsu et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: